HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Shares Outstanding (2014 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Shares Outstanding (Entity) came in at $174.5 million in Q4 2025, little changed year-over-year from $174.3 million in Q4 2024, and little changed quarter-over-quarter from $174.3 million in Q4 2024.

Analysis

HUTCHMED (China) (HMDCF) Shares Outstanding (2014 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Shares Outstanding (Entity) for 12 consecutive years, with $174.5 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Shares Outstanding (Entity) changed 0.08% year-over-year to $174.5 million in Q4 2025; TTM through Dec 2025 was $174.5 million, a 0.08% change from a year earlier, with the FY2025 full-year figure at $174.5 million, changed 0.08% from the prior year.
  • Shares Outstanding (Entity) was $174.5 million for Q4 2025 at HUTCHMED (China), roughly flat from $174.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $174.5 million in Q4 2025 and troughed at $172.9 million in Q4 2021.
  • A 5-year average of $173.8 million and a median of $174.3 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) grew 18.8% in 2021 and climbed 0.03% in 2022, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $172.9 million in 2021, then grew by 0.03% to $173.0 million in 2022, then rose by 0.75% to $174.3 million in 2023, then rose by 0.04% to $174.3 million in 2024, then gained by 0.08% to $174.5 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $174.5 million (Q4 2025), $174.3 million (Q4 2024), and $174.3 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 212.35 Bn 198.36 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 181.19 Bn 178.01 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 132.48 Bn 124.62 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 82.59 Bn 74.60 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 61.45 Bn 56.27 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.89 Bn 49.75 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 34.21 Bn 30.90 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.38 Bn 30.10 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.81 Bn 29.81 Bn 1.16 Mn 720.78 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 171.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 171.66 Mn
Dec 31, 2025 171.66 Mn
Jun 30, 2025 171.07 Mn
Dec 31, 2024 171.07 Mn
Jun 30, 2024 169.93 Mn
Dec 31, 2023 169.93 Mn
Jun 30, 2023 169.43 Mn
Dec 31, 2022 169.43 Mn
Jun 30, 2022 158.54 Mn
Dec 31, 2021 158.54 Mn
Sep 28, 2021 139.59 Mn
Jun 30, 2021 139.59 Mn
Mar 31, 2021 139.59 Mn
Dec 31, 2020 139.59 Mn
Jun 30, 2020 133.14 Mn
Mar 31, 2020 133.14 Mn
Dec 31, 2019 133.14 Mn
Sep 30, 2019 132.85 Mn
Jun 30, 2019 132.85 Mn
Mar 31, 2019 132.85 Mn